Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02D malaria vaccine in infants living in a malaria-endemic region

被引：0

作者：

Salim Abdulla

Nahya Salim

Francisca Machera

Richard Kamata

Omar Juma

Mwanajaa Shomari

Sulende Kubhoja

Ali Mohammed

Grace Mwangoka

Thomas Aebi

Hassan Mshinda

David Schellenberg

Terrell Carter

Tonya Villafana

Marie-Claude Dubois

Amanda Leach

Marc Lievens

Johan Vekemans

Joe Cohen

W Ripley Ballou

Marcel Tanner

机构：

[1] Bagamoyo Research and Training Centre of Ifakara Health Institute,

[2] Muhimbili University of Health and Allied Sciences,undefined

[3] Swiss Tropical and Public Health Institute,undefined

[4] Tanzania Commission for Science and Technology,undefined

[5] London School of Hygiene and Tropical Medicine,undefined

[6] PATH Malaria Vaccine Initiative,undefined

[7] GlaxoSmithKline Biologicals,undefined

[8] University of Basel,undefined

[9] Ifakara Health Institute,undefined

来源：

Malaria Journal | / 12卷

关键词：

RTS,S/AS02; Malaria; Infants; Immunogenicity; Safety; Efficacy; EPI;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
Agnandji, Selidji Todagbe
Lell, Bertrand
Fernandes, Jose Francisco
Abossolo, Beatrice Peggy
Kabwende, Anita Lumeka
Adegnika, Ayola Akim
Mordmueller, Benjamin
Issifou, Saadou
Kremsner, Peter Gottfried
Loembe, Marguerite Massinga
Sacarlal, Jahit
Aide, Pedro
Madrid, Lola
Lanaspa, Miguel
Mandjate, Sofia
Aponte, John J.
Bulo, Helder
Nhama, Abel
Macete, Eusebio
Alonso, Pedro
Abdulla, Salim
Salim, Nahya
Mtoro, Ali Takadir
Mutani, Paul
Tanner, Marcel
Mavere, Caroline
Mwangoka, Grace
Lweno, Omar
Juma, Omar Ali
Shekalaghe, Seif
Tinto, Halidou
D'Alessandro, Umberto
Sorgho, Hermann
Valea, Innocent
Ouedraogo, Jean Bosco
Lompo, Palpouguini
Diallo, Salou
Traore, Ousmane
Bassole, Armand
Dao, Edgard
Hamel, Mary J.
Kariuki, Simon
Oneko, Martina
Odero, Chris
Otieno, Kephas
Awino, Norbert
Muturi-Kioi, Vincent
Omoto, Jackton
Laserson, Kayla F.
Slutsker, Laurence
PLOS MEDICINE, 2014, 11 (07)
[32] A randomized, observer-blind trial to compare safety and immunogenicity of two adjuvanted RTS,S anti-malaria vaccine candidates in gabonese children
Lell, Bertand
Agnandjil, Selidji
von Glasenapp, Isabelle
Oyakhiromen, Sunny
Haertle, Sonja
Kremsner, Peter G.
Ramboer, Isabelle
Lievens, Marc
Ballou, Ripley
Vekemans, Johan
Dubois, Marie-Claude
Demoitie, Marie-Ange
Cohen, Joe
Villafana, Tonya
Carter, Terrell
Petersen, Carolyn
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (05): : 3 - 3
[33] Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
Kester, Kent E.
Cummings, James F.
Ofori-Anyinam, Opokua
Ockenhouse, Christian F.
Krzych, Urszula
Moris, Philippe
Schwenk, Robert
Nielsen, Robin A.
Debebe, Zufan
Pinelis, Evgeny
Juompan, Laure
Williams, Jack
Dowler, Megan
Stewart, V. Ann
Wirtz, Robert A.
Dubois, Marie-Claude
Lievens, Marc
Cohen, Joe
Ballou, W. Ripley
Heppner, D. Gray, Jr.
JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (03): : 337 - 346
[34] RTS,S/AS01 Malaria Vaccine Efficacy is Not Modified by Seasonal Precipitation: Results from a Phase 3 Randomized Controlled Trial in Malawi
Larry Han
Michael G. Hudgens
Michael E. Emch
Jonathan J. Juliano
Corinna Keeler
Francis Martinson
Portia Kamthunzi
Gerald Tegha
Marc Lievens
Irving F. Hoffman
Scientific Reports, 7
[35] RTS, S/AS01 Malaria Vaccine Efficacy is Not Modified by Seasonal Precipitation: Results from a Phase 3 Randomized Controlled Trial in Malawi
Han, Larry
Hudgens, Michael G.
Emch, Michael E.
Juliano, Jonathan J.
Keeler, Corinna
Martinson, Francis
Kamthunzi, Portia
Tegha, Gerald
Lievens, Marc
Hoffman, Irving F.
SCIENTIFIC REPORTS, 2017, 7
[36] Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa
Mendoza, Yolanda Guerra
Garric, Elodie
Leach, Amanda
Lievens, Marc
Ofori-Anyinam, Opokua
Pircon, Jean-Yves
Stegmann, Jens-Ulrich
Vandoolaeghe, Pascale
Otieno, Lucas
Otieno, Walter
Owusu-Agyei, Seth
Sacarlal, Jahit
Masoud, Nahya Salim
Sorgho, Hermann
Tanner, Marcel
Tinto, Halidou
Valea, Innocent
Mtoro, Ali Takadir
Njuguna, Patricia
Oneko, Martina
Otieno, Godfrey Allan
Otieno, Kephas
Gesase, Samwel
Hamel, Mary J.
Hoffman, Irving
Kaali, Seyram
Kamthunzi, Portia
Kremsner, Peter
Lanaspa, Miguel
Lell, Bertrand
Lusingu, John
Malabeja, Anangisye
Aide, Pedro
Akoo, Pauline
Ansong, Daniel
Asante, Kwaku Poku
Berkley, James A.
Adjei, Samuel
Agbenyega, Tsiri
Agnandji, Selidji Todagbe
Schuerman, Lode
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (10) : 2386 - 2398
[37] Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
Tinto, H.
D'Alessandro, U.
Sorgho, H.
Valea, I.
Tahita, M. C.
Kabore, W.
Kiemde, F.
Lompo, P.
Ouedraogo, S.
Derra, K.
Ouedraogo, F.
Ouedraogo, J. B.
Ballou, W. R.
Cohen, J.
Guerra, Y.
Heerwegh, D.
Jongert, E.
Lapierre, D.
Leach, A.
Lievens, M.
Ofori-Anyinam, O.
Olivier, A.
Vekemans, J.
Agnandji, S. T.
Lell, B.
Fernandes, J. F.
Abossolo, B. P.
Kabwende, A. L.
Adegnika, A. A.
Mordmueller, B.
Issifou, S.
Kremsner, P. G.
Loembe, M. M.
Bache, E.
Alabi, A.
Owusu-Agyei, S.
Asante, K. P.
Boahen, O.
Dosoo, D.
Asante, I.
Yidana, Z.
Anim, J.
Adeniji, E.
Yawson, A. K.
Kayan, K.
Chandramohan, D.
Greenwood, B.
Ansong, D.
Agbenyega, T.
Adjei, S.
LANCET, 2015, 386 (9988): : 31 - 45
[38] PHASE II, RANDOMIZED TRIAL TO ASSESS THE SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINES RTS,S/AS02 AND RTS,S/AS01 WHEN GIVEN ACCORDING TO DIFFERENT VACCINATION SCHEDULES IN CHILDREN IN GHANA
Owusu-Agyei, Seth
Ansong, D.
Asante, K. P.
Owusu-Kwarteng, S.
Owusu, R.
Brobby, N. A. Wireko
Dosoo, D.
Akoto, A. Y. Osei
Osei-Kwakye, K.
Adjei, E. Asafo
Boahen, K. Owusu
Sylverken, J.
Adjei, G.
Sambian, D.
Vekemans, J.
Ofori-Anyinam, O.
Lievens, M.
Demoitie, M.
Cohen, J.
Ballou, W. R.
Savarese, B.
Greenwood, B.
Bawa, T.
Evans, J.
Agbenyega, T.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 9 - 9
[39] A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naive adults
Cummings, J. F.
Polhemus, M. E.
Kester, K. E.
Ockenhouse, C. F.
Gasser, R. A.
Coyne, P.
Wortmann, G.
Nielsen, R. K.
Schaecher, K.
Holland, C. A.
Krzych, U.
Tornieporth, N.
Soisson, L. A.
Angov, E.
Heppner, D. G.
VACCINE, 2024, 42 (12) : 3066 - 3074
[40] Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial
Thera, Mahamadou A.
Doumbo, Ogobara K.
Coulibaly, Drissa
Laurens, Matthew B.
Kone, Abdoulaye K.
Guindo, Ando B.
Traore, Karim
Sissoko, Mady
Diallo, Dapa A.
Diarra, Issa
Kouriba, Bourema
Daou, Modibo
Dolo, Amagana
Baby, Mounirou
Sissoko, Mahamadou S.
Sagara, Issaka
Niangaly, Amadou
Traore, Idrissa
Olotu, Ally
Godeaux, Olivier
Leach, Amanda
Dubois, Marie-Claude
Ballou, W. Ripley
Cohen, Joe
Thompson, Darby
Dube, Tina
Soisson, Lorraine
Diggs, Carter L.
Takala, Shannon L.
Lyke, Kirsten E.
House, Brent
Lanar, David E.
Dutta, Sheetij
Heppner, D. Gray
Plowe, Christopher V.
PLOS ONE, 2010, 5 (02):

← 1 2 3 4 5 →